BMO maintains Outperform on Axalta stock with $51 target

Tuesday, BMO Capital Markets maintained their Outperform rating on Axalta Coating Systems (NYSE:AXTA) with a steady price target of $51.00. BMO Capital analysts highlighted the company’s potential for nearly 40% upside, despite facing significant foreign exchange headwinds and softer end-markets. Axalta’s management has been recognized for effectively mitigating risks through strategic pricing, cost efficiency measures, and substantial market share gains. InvestingPro data reveals management’s commitment through aggressive share buybacks, with the company maintaining a strong financial health score of GREAT.

The analysts pointed out that these efforts have positioned Axalta to achieve higher-than-sector earnings per share growth, even amid challenging conditions. They expect the company to deliver high single-digit to low double-digit EPS growth, with InvestingPro showing a current P/E ratio of 25.4x and projected EPS of $2.17 for 2024. This optimistic outlook is further supported by Axalta’s strong free cash flow of $517.4 million and an enhanced balance sheet, which BMO Capital believes will allow for increased shareholder value through targeted mergers and acquisitions and share buybacks in 2025. For deeper insights into Axalta’s valuation metrics and growth potential, investors can access the comprehensive Pro Research Report, available exclusively on InvestingPro.

Axalta’s proactive strategies in pricing and cost management, along with their successful market share expansion, have been key factors in their ability to outpace growth in their respective end-markets. With a current ratio of 2.0 and revenue growth of 2.7%, the company demonstrates solid operational execution. BMO Capital’s reaffirmation of the Outperform rating reflects confidence in Axalta’s continued execution of these strategies.

The company’s financial flexibility has been bolstered by solid free cash flow generation and balance sheet improvements. This financial strength is expected to support Axalta’s capacity to pursue accretive bolt-on acquisitions and share repurchase programs, which are seen as potential catalysts for further enhancing shareholder returns.

In conclusion, BMO Capital Markets’ analysis underscores Axalta’s resilience in the face of sectoral headwinds and their capability to drive growth and shareholder value through strategic initiatives. The firm’s maintained Outperform rating and $51.00 price target reflect a belief in the company’s promising trajectory and potential for significant stock appreciation.

In other recent news, Axalta Coating Systems has been the subject of several noteworthy developments. Citi analyst Pat Cunningham adjusted the price target for Axalta, raising it from $40 to $42, while maintaining a neutral rating. This adjustment comes after Axalta’s recent earnings call, where the company highlighted its successful expansion in China’s Light Vehicle segment and projected steady performance in its Industrial segment.

Axalta also reported fourth-quarter earnings that exceeded analyst expectations, posting adjusted earnings per share of $0.60 and revenue of $1.31 billion. The company’s net sales increased by 1% year-over-year to $1.3 billion, and net income rose by 85% to $137 million. Axalta anticipates full year 2025 net sales of $5.35 billion to $5.4 billion and Adjusted EBITDA of $1.15 billion to $1.175 billion.

In other company news, Pulse Biosciences (NASDAQ:PLSE) announced the appointment of Jon Skinner as its new Chief Financial Officer. Skinner, previously Vice President of Finance and Corporate Development at Imperative Care and holding leadership roles at Teleflex (NYSE:TFX) and Axalta, is expected to support the scaling of Pulse Biosciences’ commercialization and operational activities.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.